ScholarIQanswers from OpenAlex

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

PaperCitations, authors & open-access status

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma have?

ScholarIQcitation count

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma has 864 citations in the OpenAlex counts ScholarIQ stores.

When was Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma published?

ScholarIQyear

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma has 2010 year in the ScholarIQ index.

What is the open-access status of Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma?

ScholarIQoa status

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma has green oa status in the ScholarIQ index.

What is the DOI of Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma?

ScholarIQdoi

The DOI for Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma is on the source record.

What is the PMID of Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma?

ScholarIQpmid

The PMID for Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma is on the source record.

What is the OpenAlex record for Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma?

ScholarIQopenalex

The OpenAlex for Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial